Intensive care in cases with thoracic and extrathoracic malignant solid tumours: Indications and survival
More details
Hide details
Department Respiratory Intensive Care Unit, Yedikule Chest Disease and Surgery Training and Research Hospital, Istanbul, Turkey
Department of Pulmonary Medicine, School of Medicine, Istanbul Bilim University, Istanbul, Turkey
Department of Anesthesia and Reanimation, Haseki Training and Research Hospital, Istanbul, Turkey
Corresponding author
Levent Dalar   

Department of Pulmonary Medicine, School of Medicine, Istanbul Bilim University, Istanbul, Turkey
Pneumon 2015;28(3):222-229
The patients with thoracic and extra-thoracic solid organ tumours hospitalized in the intensive care unit (ICU) were retrospectively analyzed and the effects of their ICU stays on survival rates were investigated.

Medical files of the patients hospitalized in the adult ICUs between January 2010 and September 2013 were retrospectively investigated. ICU stays of the cases with solid organ tumours were evaluated and survival related factors were analyzed. The correlation between available parametres and survival rates was analyzed.

A total of 87 patients (74 males) with a mean age of 64.07 ± 11.90 years were included in the study. The cases were divided into 2 groups as those with thoracic (n = 52; 59.8%) and extrathoracic (n = 35; 40.2%) malignancies. Thoracic malignancies were divided within themselves into two subgroups as SCLC (n = 11; 21.2%) and NSCLC (n = 41; 78.8%) and their survival rates were compared. Respiratory failure (n = 35; 40.2%), respiratory failure and additional indications (n = 37; 42.5%) and other indications (n = 15; 17.2%) were main indications. Mean duration of ICU stays was 12.95 ± 16.48 days (range 1-105). Fifty (57.5%) cases died, 6 (6.9%) patients transferred to another center and 31 cases (35.6%) were discharged. Hospitalization times of the cases with respect to mortality rates were significantly different (p = 0.014). Mean survival was 6.78 ± 1.81 months and six month-survival rate was 29.7%.

Treatment of patients with thoracic and extra-thoracic solid organ tumours in the ICU increases their survivals; however, admission of cancer patients into an ICU should be based on certain objective criteria.

Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
Eser S, Yakut C, Özdemir R, et al. Cancer Incidence Rates in Turkey in 2006: A Detailed Registry Based Estimation Asian Pasific J Cancer Prev 2010;11:1731-9.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. İntensive care, survival and expense of treating critically il cancer patients. JAMA 1993;269:783-6.
Reichner CA, Thompson JA, O’Brien S, Kuru T, Anderson ED. Outcome and code status of lung cancer patients admitted to the medical ICU. Chest 2006;130:719-23.
Soares M, Darmon M, Salluh JI, et al. Prognosis of lung cancer patients with life-threatening complications. Chest 2007;131:840-6.
Adam AK, Soubani AO. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit. Eur Respir J 2008;31:47-53.
Toffart AC, Minet C, Raynard B, et al. Use of intensive care in patients with nonresectable lung cancer. Chest 2011;139:101-8.
Roques S, Parrot A, Lavole A, et al. Six month prognosis of patients with lung cancer admitted to the intensive care unit. İntensive Care Med 2009;35:2044-50.
Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
Griffin JP, Nelson JE, Koch KA, et al; American College of Chest Physicians. End-of-life care in patients with lung cancer. Chest 2003;123:S312-S31.
Sharma G, Freeman J, Zhang D, Goodwin JS. Trends in end-oflife ICU use among older adults with advanced lung cancer. Chest 2008;133:72-8.
Nelson JE, Meier DE, Oei EJ, et al. Self reported symptom experience of critically il cancer patients receiving intensive care. Crit Care Med 2001;29:277-82.
Bonomi MR, Smith CB, Mhango G, Wisnivesky JP. Outcomes Of Elderly Patients With Stage IIIB – IV Nonsmall Cell Lung Cancer Admitted To The İntensive Care Unit. Lung Cancer 2012;77:600-4.
Chou KT, Chen CS, Su KC, et al. Hospital Outcomes For Patients With Stage III And IV Lung Cancer Admitted To The İntensive Care Unit For Sepsis – Related Acute Respiratory Failure. J Palliat Med 2012;15:1234-9.
Slatore CG, Cecere LM, Letourneau JL, et al. Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results-medicare registry. J Clin Oncol 2012;30:1686-91.
Azoulay E, Thiéry G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004;83:360-70.
Zarogoulidis P, Pataka A, Terzi E, et al. İntensive care unit and lung cancer: when should we intubate? J Thorasic Dis 2013;5(S4):S407-S12.
Medarov B,Challa TR. Short-term Mortality Among Patients with Non-small Cell Lung Cancer and Respiratory Failure: A Retrospective Study. Chest Disease Reports 2011;1:e7.
Anisoglou S, Asteriou C, Barbetakis N, Kakolyris S, Anastasiadou G, Pnevmatikos I. Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure. Hippokratia 2013;17:60-3.
Journals System - logo
Scroll to top